ClinicalTrials.Veeva

Menu

Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion

P

Planned Parenthood League of Massachusetts

Status

Completed

Conditions

Undesired Pregnancy

Study type

Observational

Funder types

Other

Identifiers

NCT02179944
2014p000824
SFPRF14-20 (Other Grant/Funding Number)

Details and patient eligibility

About

This project will be a prospective physiologic study. We will closely follow 60 medication abortion patients with serial repeat serum hCG and urine semi-quantitative hCG testing. We plan to recruit patients from two gestational age strata: ≤ 49 days and > 49 days.

Study Objectives:

  1. To create a nomogram describing the change in serum hCG values in the first five days immediately following medication abortion with mifepristone and misoprostol. Specifically, we will describe the percent serum hCG decline from Day 1 (day of mifepristone) to Day 3 (day after misoprostol), from Day 1 to Day 5, and from Day 1 to Day 7-10.
  2. To explore whether there is a significant difference in the rate of hCG decline based on initial gestational age determined by ultrasound and initial serum hCG.
  3. To describe the correlation between semi-quantitative urine hCG test results and serum hCG values to determine how soon after initiating medication abortion the urine test can detect completed abortion.

We hypothesize that among successful medication abortions, there will be a predictable trend with at least a 50% drop by Day 3 and 80% drop by Day 5.

Enrollment

66 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Desire for medication abortion for pregnancy termination AND
  • Pregnancy confirmed by ultrasound and gestational age ≤ 63 days based on transvaginal ultrasound (TVUS) OR
  • Positive high-sensitivity urine hCG and intrauterine pregnancy (IUP) not confirmed on TVUS

Exclusion criteria

  • Ineligibility for medication abortion at Planned Parenthood League of Massachusetts (PPLM) based on current PPLM clinical guidelines

  • Initiation of medication abortion on Wednesday or Friday

  • Failed pregnancy defined as:

    • Crown-rump length ≥ 7mm and no heartbeat
    • Mean sac diameter ≥ 25mm and no embryo
  • Reasonable clinical suspicion for ectopic or molar pregnancy such as abnormal or concerning ultrasound findings

  • Multiple gestation

  • Age less than 18 years

  • Prior participation in this study

  • Anticipated inability to present for scheduled follow-up visits

Trial design

66 participants in 1 patient group

Participants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems